LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls

scientific article published on May 2007

LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.OPTM.2006.10.019
P8608Fatcat IDrelease_pnrvrwowwbb3pckhm4vxn3j3ue
P698PubMed publication ID17478338
P5875ResearchGate publication ID6352543

P2093author name stringStuart Richer
Jenny Devenport
John C Lang
P433issue5
P921main subjectmacular degenerationQ27429789
P304page(s)213-219
P577publication date2007-05-01
P1433published inOptometry - Journal of the American Optometric AssociationQ15753285
P1476titleLAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls
P478volume78

Reverse relations

cites work (P2860)
Q38330232An Evidence-Based Systematic Review of Lutein by the Natural Standard Research Collaboration
Q24201127Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
Q24202824Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration
Q24246241Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration
Q38653249Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Q34108927Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study
Q38529695Dietary modification and supplementation for the treatment of age-related macular degeneration
Q37083770Diminishing risk for age-related macular degeneration with nutrition: a current view
Q92320396Effects of lutein supplementation in age-related macular degeneration
Q51386596Genetic variants in BCMO1 and CD36 are associated with plasma lutein concentrations and macular pigment optical density in humans.
Q33910891Lutein protects RGC-5 cells against hypoxia and oxidative stress
Q36078526Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density
Q33705472Macular pigment density at the site of altered fundus autofluorescence
Q37229764Macular pigment optical density: repeatability, intereye correlation, and effect of ocular dominance
Q28240096Macular xanthophylls, lipoprotein-related genes, and age-related macular degeneration
Q36508346Neuroprotective effects of lutein in a rat model of retinal detachment
Q36083941Nutritional modulation of age-related macular degeneration.
Q38317289Nutritional supplements in age-related macular degeneration
Q38921719Plasma long-chain omega-3 polyunsaturated fatty acids and macular pigment in subjects with family history of age-related macular degeneration: the Limpia Study
Q64898482Protective effect of lutein on spinal cord ischemia-reperfusion injury in rats.
Q37577489Reliability of Heterochromatic Flicker Photometry in Measuring Macular Pigment Optical Density among Preadolescent Children
Q33326556Resonance Raman imaging of macular pigment distributions in the human retina
Q35130887Retinal light toxicity
Q36538104Retinal spectral domain optical coherence tomography in early atrophic age-related macular degeneration (AMD) and a new metric for objective evaluation of the efficacy of ocular nutrition
Q35744184The Effect of Zeaxanthin on the Visual Acuity of Zebrafish.
Q92615920The protective role of lutein on isoproterenol-induced cardiac failure rat model through improving cardiac morphology, antioxidant status via positively regulating Nrf2/HO-1 signalling pathway
Q33733227The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders
Q52916673[Vitamins for the eyes? Risks and opportunities for physician and patient].

Search more.